Council for Tobacco Research
A Capabilities Statement for Inhalation Toxicology Studies Using A Nose-Only Inhalation System [Model System for Conducting Inhalation Toxicology Studies Using Rodents Exposed to Aerosolized Materials Via Only Nasal Orifice]
Fields
- Type
- REPORT
- BIBLIOGRAPHY
- SPECIFICATIONS
- BIBLIOGRAPHY
- Depository Date
- 31 Jan 1996
- Named Person
- Nci
- Niamdd
- Nidr
- Niaid
- Nincds
- Ornl
- Nichd
- Hall, W.C.
- Univ, C.A. Irvine
- Univ, C.A. San Francisco
- Childrens Hospital, O.F. Los Angeles
- Baylor College, O.F. Medicine
- Georgetown Univ
- Univ, S.C.
- Univ, M.D.
- Kouri, R.E.
- Henry, C.J.
- Niamdd
- Master ID
- 300200314-0407
Related Documents:- HT0120003-0004 [Addresses Development of Nose Only Model Inhalation System to Be Tested on Animals to Understand Human Implications.]
- HT0120005-0008 Microbiological Associates Nose-Only Inhalation System [Unique System Designed by Mai for Research and Testing Needs of Fed Govt and Industrial Clients.]
- HT0120034-0055 A Capabilities Statement for Inhalation Toxicology Studies of Whole Cigarette Smoke and, or Aerosolized Chemicals Using An Animal Model and Nose-Only Inhalation System. [System Which Examines Effects of Whole Cigarette Smoke Using Exposure of Rodents by Inhalation of Smoke Via Nasal Orifice.]
- HT0120056-0080 Deposition and Distribution of the Total Particulate Matter of Cigarette Smoke in Mice Using A Large Capacity Smoke Exposure System [Studies Effects of Cigarette Smoke Using Sem 2]
- HT0120081-0096 the Dosimetry and Distribution of Whole Cigarette Smoke Particulates in Inbred Strains of Mice Comparison of A Large Smoke Exposure Machine (Sem with A Small-Capacity Smoke-Exposure Machine (Walton) [St This Study Was Made Using Small and Large Models of Smoking Machines; A Radioactive Tracer Was Used to Quantitate the Deposition of Tpm in Mouse Tissues Which Had Been Exposed to Smoke; the Percentage Distribution of Particulates in the Lungs and Respiratory Tract Was Determined for Animals Exposed on the Machines]
- Request
- 132
- Author
- Henry, C., Mai
- Kanagalingam, K.K., Mai
- Hall, W.C., Mai
- Kouri, R.E., Mai
- Kanagalingam, K.K., Mai
- Box
- 098
- Site
- Hoyt
- UCSF Legacy ID
- gqd1aa00
Document Images
I
H T®012000!
A CAPABILITIES STATEMENT FOR
INHALATION TOXICOLOGY STUDIES
USING A NOSE-ONLY INHALATION SYSTEM
Prepared by
Carol J. Henry. Ph.D.
Ken K. Kanagalingam, Ph.D.
William C. Hall, V.M.D., Ph.D.
Richard E. Kouri, Ph.D.
March 18, 1981
Microbiological Associates
5221 River Road
Bethesda, Maryland 20016
(301) 654-3400
!Ka . ,1g~+~btiolo~iC~d :~5s0C1a~
-q'.M-S

a
H TM01 20010
I. INTRODUCTION
C
The human health effects of exposure to chemicals, both
alone and in conjunction with other environmental and occupa-
tional agents. continues to be of major public concern. Today,
some 30 goverranent agencies and many industrial and research
organizations are actively working to identify and char3cterize
potentially hazardous substances and to understa,zd the human
health implications of exposure to these compounds.
A significant route of exposure for introducing toxic and
other hazardous substances to the body is through the respiratory
tract. Each day, adults respire 10,000 to 20.000 liters of air
containing particulates such as occupational and atmospheric
dusts, commercial aerosol products, smokes, radioactive parti-
cles, and other noxious agents. In addition, a large portion of
the population voluntarily inhales one particular complex aero-
sol. cigarette smoke. Respirable aerosols are deposited along
the entire respiratory tract, and probably play a significant
role in initiating or exacerbating a variety of pulmonary, car-
diovascular, or infectious diseases.
The mechanisnt by which these agents exert such wide ranging
toxicological and/or carcinogenic effects is not known. These
processes have been postulated to occur in multiple steps
(Figure 1), many of which have been studied in detail (18)-
Given the complexity of the biologic response, an important
aspect of experimental inhalation studies concerns limiting the
route of exposure to or.ly that which is inhaled and avoiding
dermal or oral exposures.
Microbiological Associates (MA) has evclved a model system
for conducting inhalation toxicology stud3es by uhich rodents,
which are obligate nose-breathers, are exposed to aerosolized
materials via oEIX the nasal orifice. MA has implemented these
studies under a program of stringent ani.roal health requirements,
thereby min:mizing unknown interactions orr synergistic effects,
so that the endpoints of these studies are not compromised.
' .1'IiC1obi01"icswl Usocha
1 r_._~..,:..-

11. OF3JECTIVES
MT®0120011
MA is now in a position to make available its "state of the
art" approach to inhalation toxicology. During the last 8 years
MA has been the prime contractor for the development, implementa-
tion and characterization of a pulmonary toxicology bioassay in
rodents. This has enabled us to a) develop specialized equipment
not only for the generation, delivery and monitoring of a variety
of aerosolized materials, but also develop a rapid, safe, and
effective animal containment system faciltating nose-only expo-
sure to these aerosols b) develop and characterize an animal
model system for pulmonary carcinogensis, and c) institute a com-
prehensive animal diagnostic laboratory in order to preclude
utilization of diseased animals for this research as well as pre-
vent introduction of infectious agents into the factlity.
This background enabLes MA to address several existing problems
in inhalation toxicology at a level of understanding which could
not be considered in the past, and which we feel has great
potential for the future.
III. CAPABILITIES
C
A. Nose Only Exposure
The animal containment system developed for nose-only expo-
sure is shown in Figure 2. Groups of five animals are placed in
a"stock-like" holder usina a combination of a neck slot and a
restraining spring (Figure 3). A chin rest insures that the nose
of the animal is aligned with the cone shaped opening on the
e--posure modules. The nose of each animal passes through a
dental rubber dam diaphragm, which forms a seal that prevents
exposure of the animal body to the aerosol. Air circulates
freely around the animals, preventtng temperature build up which
often occurs when whole body tubes are used. In adc:ition, fecal
and urine contamination is prevented by the plastic coated grid
which supports the animal in the tray. Urine and feces are
easily collected from the tray when required. Daily restraint
for up to three hours (twice per day) results in no mortality or
obvious ill effects to the animals.
B. Aerosol Generation
The animal containment unit which provides "nose-only"
exposure of the animals is compatible with any aerosol genera-
tion system which might be required. Four applications with
which MA has considerable expertise are detailed in thr follow-
ing sections.
1. 13ebulizer
A modified Kay nebulizer (17) has been employed for
aerosol generation of specific chemicals, such as catechol (1.2-
.~YCl~Ob1D~CA1 ~S50C3:~
2
2 m ~

I
HiFS G12L(;i2_
r dihydroxybenzene, a major constituent of cigarette smoke and
, shown to be a tumor promoter on mouse skin, 5) and 12-0-tetrade-
canoylphorbol-13-acetate (TPA, the active component in croton oil
and the most potent tumor promoter known. 25). Chemicals soluble
in ethanol or water have been used in this system to successfully
generate particulate aerosols of particle size -0.5 um geometric
mean diameter. The particulate deposition in mice exposed to
these aerosols has been shown to be primarily in the lung (60-
70%) and total respiratory tract ('80%).
2. Dust-generator
of this system is in progress.
A Timbrell dust generator has been recently employed
with this system to generate aerosols of UICC chrvsotile asbes-
tos. Flnoloying a vertical elutriatorr in the asbestos aerosol
stream resulted in particle sizes ranging from 0.2-10.0 um, mass
median diameter. An Anderson cascade impactor was used to with-
draw particle samples from an animal exposure hole to charac-
terize th e particle size range offered to the animal in the
aerosol stream. Complete characterization of the potential use
3. Cigarette Smoke
l
Whole cigarette smoke has been generated and charac-
terized using two different generation systems: a dynamic expo-
sure system (Figure 4) and a static or standing exposure
system (Figure 5). Specific details of these two systems may be
found in the references (4, 10, 12) and in Appendix A. Smoke was
generated under standard conditions for puff duration. puff
volume and puff frequency, and particle sizas characterized. The
deposition and internal distribution of the total particulate
matter of the smoke was determined in mice after exposure to a
wide range of experimental conditions (10, 12 and Section IV of
this document).
4. Vapors or Gases
Vapors, gases or gas phase constituents of complex aero-
sols can be generated and used in this system. Carbon.monoxide
and carbon dioxide have been used as positive controls for cer-
tain cigarette smoke exposures and an assay has been developed to
routinely detect carboxyhemoglobin in mice (9).
C. Aerosol Monitoring System
A monitoring system was developed for continuous measurement
of particulate aerosols (see Figure 6) and certain gases. The
aerosols are monitored with an optical-type scattering detector
(13). Each exposure is documented on a strip chart recorder.
which provides a permanent record of aerosol concentration and
exposure period. In the case of cigarette smoke, this monitor
provides both a puff by puff profile of each smoke exposure and a
3

I
NT00120013
r cunulative value for the total particulate matter from each
l individual exposure. The mcaitoring system also allows for con-
tinuous measurenent of carbon monoxide and carbon dioxide, either
as single constituents or when present in complex aerosols
generated during combustion proce« es. Sampling ports are
available for collecting particulates or gases for more detailed
chemical or microscopic anaJyses. Samples can be collected
immediately preceeding the animals (Figuros 2 and 6), or from any
point along the exposure module.
D. Animal Health
Health, quality, and conaistency of experimental animals are
absolutely essenti al to the production of accurate and repro-
ducible test results. Infectious agents can cause clinical
disease of laboratory animals resulting in mortality. Such
disease frequently can reduce the numbers of subjects on test
below an acceptable minLnum, will significantly effect the sur-
viving animals' response to the research proLocol, and will
result in expensive, time-consuming delays in the intended pro-
ject. Not as obvious, but of equal ly serious concern, is the
effect of subclinical infections with a variety of agents which
can alter the animal host's response to numerous toxicological
procedures.
Disease diagnosis is an essential part of the disease con-
trol program in operation at MA, an approach which MA nas helped
to pioneer. A11 animals are quarant3_ned and screened for adven-
titious agents, as outlined in Figure 7. Specif ically for long
term inhalation studies MA has used the mouse because of the
availability of colonies f-ee of two lung viruses, Sendai and
pneumonia virus of mic4. With the availability of other colonies
which are freQ of these two lung pathogens, other species can be
routinely used. As further protection during long-term studies,
a vaccine against Sendai virus has been developed within this
program The utility of this vaccine has been recently demon-
stratzd (1, 23).
IV. RELEVANT BACKGROUND STUDIES
A. Dosimetry and Distribution .
1. Cigarette Smoke Farticulates
Jsing standard smoke exposure condi-tions, the deposition
and internal distribution of the total particulate matter from
cigarette smoke has been determined in various strains of mice
(10. 11, 12). Results showr: a) smoke exposure conditions can be
varied so :iat deposition from 30 ug to 200 ug total particulate
matv'leP/lung can be obtained, b) 80-90% of the deposition of the
total par:iculate matter is found in the respiratory tissues.
c) the mouse-to-mouse variaticn for particulate deposition in
pulmonary =issue is -20$, d) similar deposition ana distribution
4 /.~lo M....~ical :As5ocia

H TM0120014
of particulates are observed in both male and female mice, and
e) deposition and distribution of particulates are not altered in
mice exposed to smoke on a daily basis for over 6 months. Depo-
sition, distribution and clearance of a specific constituent of
smoke are dependent upon the metabolic fate and chemical class of
constituent used. The pharmacokinetics of four particulate phase
constituents of cigarette smoke have been studied in our labora-
tories (11 15, 16). Measurements of carboxyhemoglobin levels
reflect the uptake of the gas phase smoke and are highly corre-
lated with pulmonary deposition of total particulate matter (9).
2. Particulate Aerosols
The deposition and internal distribution of the
phorbolester, TPA has been determined after exposure of mice to
3B-TPA aerosols. Approximately 60-70% of the total initial
radioactivity was found in the pulmonary tissues immediately
after the exposure period, with rapid loss of radioactivity from
the lung ( tIs -30 minutes ) and total body ( t.4 .-24 hours ).
This exposure system with TPA has been used in our laboratories
to specifically induce pulmonary ornithine decarboxvlase, an
enzyme which is rate Limiting in polyamine biosynthesis and
thought to be a marker for tumor promotion (3, 25). Similar
aerosol experiments are in progress with catechol (15, 16).
B. End-Points for Chemically Induced Lung Cancer
1. Pathology
Well defined histopathologic criteria have been estab-
lished for both acute and chronic exposure to model chemicals and
whole cigarette smoke. These criteria have resulted from micro-
scopic analysis of tissues using Light microscopy, transmission
electron microscopy and scanning electron microscupy. The inbred
strains of iaice have been used as an animal model for lung cancer
with model chemicals and have been shown to express those types
of lung cancer normaLly associated with cigarette smohing in
humans (e.g., squamous cell carcinomas, alveolar adenocarcinomas,
adenosquamous carcinomas and poorly differentiated carcinomas, 2.
6, 7). As has been suggested in humans, susceptibility to lung
cancer in mice seems be genetically regulated, and is linked to
a higher capacity to metabolize certain chemical carcir.ogens
(18, 19, 20, 21). Morphologic criteria have been rigorously
defined for preneoplastic and neoplastic lung lesions in mice
treated with model chemicals, thereby demonstrating the potential
of the system for the evaluation of the biological effects of
unknown chemicals or treatments (2, 6, 7).
Experimental conditions can be designed so that 80-90%
of the mice die from pulmonary carcinomas ',H. 7). T%aus a model
system is available to study the induction, expression and pro-
gression of lung tumors under conditions where a large proportion
of the animals express a neoplastic response.
5 ~-J° .r~a~+or,iooogica~ ~ocia

2. Short Term Markers
HT20120015
Several short-term markers have been determined for the
evaluation of the biological effects of pulmonary exposure to
intratracheally instilled chemicals, aerosols, and whole ciga-
rette smoke. These include: a) induction of microsomal mono-
oxygenases in the lung and liver (20), b) induct ion of pulmonary
ornithine decarboxylase (3, 8), c) determination of levels of
DNA repair capacity of lung tissue (24) d) determination of the
extent of DNA damage in pulmonary tissue, e) determination of
rates of pulmonary macromolpcular synthesis (i e., DNA, RNA,
protein and collagen), f) separation and identification of speci-
fic metabolites using high performance liquid chromatography, and
g) physiologic response in the lung such as the formation and
persistence of aberrant cell types as measured by both light and
electron microscopy.
V. FACII,ITIES
Smoke inhalation experiments are carried out in our inhala-
tion facility, which occupies 8000 square feet and employs 25
individuals. The facility has restricted access to ensure the
health of the animals. A gas powered generator provides emer-
gency power in the event of power failure. Fresh, filtered
air, regulated for temperature and humidity, is provided to the
animal rooms. Air to the animal rooms is not recirculated and
is changed at the rate of 10-12 room changes of air per hour
Rooms are monitored 24 hours per day for changes in te,nperature
by an alarm system, which notifies responsible personnel in the
event of a malfunction. A cage washer and autoclave are avail-
able tor sterilization of food, bedding, and cages.
Chemical fume hoods and Type II, Class II hoods are equipped
with charcoal and HEPA filters. Specialized laboratory equipment
available for the inhalation fac:ility includea Instrumentation
Laboratory CO-oxirrater, a Packard Tissue Oxidizer, Leitz Ortho-
plan binocular compound microscope, Psrkin-zlmer Gas Chromato-
graph, Beckman Infra-rad ultraviolet./visible Spectrophotometer,
Aminco-8owman Spectrophotofluorometers, Beckman Scintillation
Counters, and Sartorius remote control, balance interlaced to a
Hewlett Packard terminal for automatic animal weighing.
0 .1~i~bi010~ :~ia
~6 m ~,

vI . PERSONN'..L N iC-012 0 016
~..
The seven Ph. D.' s = nvolved in these studies have a wide
range of technical expertise in the biological and chemical
sciences. Their combined experience has resulted in significant
contributions to the fields of tcxicology, carcicogenesis, and
biochemisty, resulting ia over 100 publicationr This research
team is aided by a well qualified and trained technical staff
(M. S., B. S., and AALAS certified ) and is involved in ongoing col-
laborative efforts with colleagues at such institutions as NCI;
.LCRD NIA"D; =Br .1IAID; NIVCDS; Oak Ridge aational Labo-
ratory; University of California, Irvine; University of Call-
fornia, San Francisco: Cl:ildren's dospital, Los Angeles: 3aylor
College of Medicine; Georgetown University: University of South
Carol:nar and University of Maryland.
MA also has extensive expertise in the areas of veterinary
care, veterinary pathology, histology, and data processing. The
Animal Disease Diagnostic ±es:.ir.g Laboratory is under the super-
vision of a veterinarian, board certiEied in animal pathology.
Four of the 7 member staff in the histology department are
cert=fied in histotechnology. The Data Processing depar t-ment is
domprised of 6 professionals with expe_ience rang:nS from compu-
ter science to automated statistical applications.
\
7
}W f ° 1iie:vbiol4cal Uw.'

H T®01 20017
(
APPENDIX A
SMOKE-GMtERATION SYSTEMS
I. Small Capacity, Static System
The Walton Horizontal Smoke Exposure Machine is shown in
text Figures 5a and Sb. This machine is designed to expose a
small number of experimental animals (12-20 mice, 12 rats or
hamsters) to cigarette smoke under the conditions of a 2-sec
puff, 35 ml puff volume and one puff per minute. The features
of this machine have been described elsewhere (6, 11). The
Walton provides exposure to standing or static smoke from a
single puff that is uniformly mixed by a rotating fan. The
animals breathe the smoke for a preselected time ranging from S
to 45 sec. The particle size for of the smoke aerosol has a
a geometric mean diameter of 0.40 to 0.63 um during a 30 sec
exposure period (14). The chamber is flushed with fresh air
between puffs. The smoke concentration can be varied by changing
either the chamber volume (between 384 and 1150 ml) or the number
of cigarettes (up to 3) simultaneously smoked.
It. Large Capacity, Dynamic System
The Smoke Exposure Machine (SEM II) is a dynamic exposure
system which has the capacity to expose up to 480 mice to smoke
at any one time. The SEM-II shown in text Figure 4, operates in
a manner simulating human smoking and automatically and seque n-
tially loads. lights, puffs, ejects, and extinguishes a series of
30 cigarettes. The operatiag principles of this machine are pre-
sented elsewhere (22). Tt:e standard smoking conditions employed
are: puff frecuency (one/minute), puff A»-ation (2 secor.us),
average puff volume (35 ml) and cigarotte butt length (23 mm
average). These conditions are malntained independently of the
aaimal containment system. Variable amounts of dilution air can
be introduced at the butt end of the cigarette allowing a range
of smoke concentrations from 5-100$ (w/v) to be offered to the
test animals. A diagram of the smoke generation system ar.d
animal contairunenrt unit is presented in text Figure 7. Smoke can
Le alternated with breathing air for various intervals*within a
one minute cycle. Air is provided to all channels in the absence
of smoke. Cigarette smoke is delivered to the test animals with-
in 2 seconds after generation at the cigarette. Previous studies
have shown that smoke particle size was log normally distributed
with a geometric mean diameter of 0.34 microns and geometric
standard deviation of 1.35 microns (14).
8
s . ~ . .
~ ` ~~~

HT®0120018
REFERENCES
1. Bealmear, P.M., Lahuada, C.P. Osmani, B., Freimark, B.
Seeger, T., Mirand, E.A., Holterman, O.A. Amelioration of
the Immunosuppressive Effects of Sendai Virus on the Mouse
by Vaccination. Proc. Am. Assoc. for Lab. Animal Sci. #90A,
(1980).
2. Billups, L.H., Henry, C.J., Whitmire, C.E. Kouri, R.E.
Pathogenesis of Chemically Induced Lung Lesions in Mice.
Proc. Am. Assoc. Can. Res. 19 (1978) 142.
3. Dinowitz, M., Nims, R., Bhooshan, B., Kouri, R.E., Henry,
C.J., Induction of Ornithine Decarboxylase (ODC) by 12-0-
Tetradecanoylphorbol-13-acetate (TPA) in Pulmonary Tissue: A
Model System for Tumor Promotion in Mouse Lungs. Proc. Am.
Assoc. Cancer Res. 21 (1980) 31.
4. Guerin, M.R., Stokely, J.R., Higgins, C.E., Moneyhun, J.H.,
and Holmberg, R.W. Inhalation Bioassay Chemistry -- Walton
Horizontal Smoking Machine for Inhalation Exposure of Rod-
ents to Cigarette Smoke. J. Nazl. Cancer Inst. 63 (1979)
441.
5. Hecht, S S., Carmella, 5., Mori. H.. Hoffmann D. A Study
of Tobacco Carcinogen X4C. Role of Catechol as a Major Co-
carcinogen in the Weakly Acidic Fraction of Smoke Conden-
sate. J. Natl. Cancer Inst. 66 (1981) 163.
6. Henry, C.J. Billups, L.H., A:ery, M.D. Dansie, D.R..,
Lopez, A., Breth, L.A., Rude, 'C.. Kouri, R.E. Lung Cancer
Model Systems in Inbred Strains of Mice Proc. Am. Assoc.
Can. Res. 20 (1979) 242.
7. Henry, C.J., Billups, L.H., Avqry, M.D , Rude, T., Dansie,
D.R., Lopez, A., Sass, B., Whit.zirE., C.E., :Couri, R.E. A
Lung Cancer Model System Using Lzbred Strains of Mice
Submitted (1981).
S. Henry, C.J., Billups, L.H., Dinowitz M. Rasmussen, R.E.,
Avery, M.D., Dansie, D.R., Lopez, A., Breth, L.A.', Mullinax,
H.D., Kouri, R.E The Effect of Exposure to Whole Cigarette
Smoke on Pulmonary Mixed Function Oxidase, Ornithine Decar-
boxylase, DNA Repair Capacity and on 3-Methylcholaiitbrene
(MCA) Induced Lung Tumors in BC3F1/Cum Mice. In: Symposium
on Cocarcinogenesis and Biological Effects of Tumor Pro-
moters. October 13-16, 1980. Castle of Elmau, Bavaria,
Federal Republic of Germany p. 56.
9. Henry, C.J., Breth, L.A., Gerhart, J.M., Dansie, D.R.,
+tullinax, H.D., Whitmire C.E., icouri, R.E. Carboxyhemo-
globin Levels as a,leasure of Cic;arette Smoke Exposure in
Mice. In preparation. (1981).
9

HT®012U1.i9
10. Henry, C.J., Caton, J.E., Stokely, J.R., Guerin, M.R.,
Lopez. A., Avery, M.D.. Dansie, D.R., Henderson G.M.,
Gayle, T. Whitmire, C.E., Kouri, R.E. Deposition and
Distribution of the Total Particulate Matter of Cigarette
Smoke in Mice using a Large Capacity Smoke Exposure System.
Toxicol. Appl.Pharmacol. (in press) (1981).
11. Henry, C.J., Lopez, A., Dansie, D.R., Avery, M.D.. Whitmire,
C.E., Caton, J.E., Stokely, J.R. Guerin, MR., Curren,
R.D., Kouri, R.E. Distribution and Clearance of Three
Cigarette Smoke Constituents, Dotriacontane (DTC), Nicotine
(NIC), and Benzo(a)oyrene (BP), after Exposure of Mice to
Whole Cigarette Smoke. The Toxicologist. 1(1981) 139.
12. Henry, C.J., Whitmire, C.E., Lopez, A., Dansie, D.R., Avery,
M.D., Caton, J.E., Stokely, J.R. Holmberg, R.W. Guerin,
M.R., Kouri, R.E. The Dosimetry and Distribution of Whole
Cigarette Smoke Particulates in Inbred Strains of Mice:
Comparison of a Large Smoke-Exposure Machine (SEM) with a
Small-Capacity Smoke-Exposure Machine (Walton). In:
Pulmonary Toxicology of Respirable Particles, C.L. Sanders,
F.T. Cross, G.E. Dagle and J.A. Mahafley, Eds. Technical
Information Center, U.S. Department of Energy, NTIS, 1980,
177-192.
13. Higgins, C.E., Gayle, T.M., Stokely, J.R. Sensor for
Detection of Tobacco Smoke Particulates in Inhalation Expo-
sure System. Beitr. Tabakforsch. 9(1.978) 185.
14. Holmberg, R.W. Determination of Particle Size in Tobacco
Smoke Inhalation Devices Using ::=thylcyanoacrylate Fixation
and Scanning Microscopy. In: Tobacco Smoke Inhalation Bio-
assay Chemistry. M.R. Guerin, J.R. Stokely, and C.E.
Higgins, Eds., DOE Report ORN'L-5422, Oak Ridge Naticnal
Laboratory. NTIS, 1979.
15. Hwang, K.K., Bhooshan, B., Kouri, R.E., Henry, C.J.
Synthesis of Tritium Labelled Catechol. J. of Labelled
Compd. and Radiopharmaceuticals. (in press) 1981.
16. Bwang, K.K., Sonko, 0., Dansie D.R., Kouri,. R.E.. Henry ,
C.J. Studies in the Deposition and Distribution of Catechol
from Whole Cigarette Smoke in SC3F1/Cum Mice After Exposure
to Smoke. In preparation. 1981.
17. Kay, K.R. The Collision vebuliz=- Description, Perfor-
mance, and Application. J. Aerosol Sci. 4 (1973) 235.
18. Kouri, R E. Genetic Differences in Chemical Carcinogenesis.
CRC Press, Boca Raton, Fla. 1980.
10 ~'f ' .`IiCrOltemlOgiCa1 .~'
l"~ .W~°~

.._~.~r ~ . ...._.-._.. ~u}..r^.~ _Y
111 h01 2GG20
C
19. Kouri, R.E., Nebert. D W. Genetic Regulation of Suscepti-
bility to Polycycl.ic-hydrocarbon-induceC Tumors in the
Mouse. in: Origins of Human Cancer Book A, Hiatt, H H..
Watson, J.D., and Winsten, J.A., Eds., Cold Spring aarbor
Laboratory, New York, 1977, 811.
20. Kouri, R.E.. Rude, T.H., Curren, R. D., Brandt, K. R. ,
Sosnowski, R.G., Schechtman, L.M., Benedict, W.F., Henry,
C.J. Biologic:ai Activity of Tobacco Smoke and Tobacco Smoke-
Related Chemicals. Environm. Blth. Perspect. 29 (1979) 63.
21. Kouri, R.E., Schechtman. L.M., Nebert, D.W. Genetic Control
of Carcinogen Metabolism. In: Genetic Differences in
Chemical Carcinogenesis. R.E. Kouri, Ed., CRC Press, Boca
Raton, Fla., 1980,21-66.
22. Moneyhun, J.H., Stokely, J.R., Florant, L. Process and
Instruments Corporation Automatic Smoke Exposure Machine --
SEM II. In: Tobacco Smoke Inhalation Bioassay Chemistry .
M.R. Guerin, J.R. Stokely, and C.E. Higgins, Eds., DOE
Report ORNL-5422, Oak Ridge National Laboratory, NTIS, 1979.
23. Parker, J.C. The Possibilities and Limitations of Virus
Control in Laboratory Animals. In; 7th ICLAS Symposium,
Utrecht 1979, Gustav Fischer Verlag, Stuttgart, .Tew York.
1980. 162-172.
24. Rasmussen, R.E., Boyd C.H., Dansie, D.R., Kouri, R.E.
Henry, C.J. DNA Replication and Unscheduled DNA Synthesis in
Lungs of Mice Exposed to Cigarette Smoke. Cancer Res. (In
press) (1981).
25. Verma, A.K.. Shapasl B.F., Rice H.M , Boutwell R.K
Correlation of the inhibition by Retino:,ds of Tumor
Promoter-Induced Mouse Epidermal Ornithine Decarboxylase
Activity and of Skin Tumor Promotion. Can. Res. 39 (1979)
419.
11 )C__- .1tiCiobiO:AsSOCib.

1-
i-.
Figure 1.
STAGES IN CARCINOGENESIS
.
('.fM .AfiCPK~GENE9iS
~-
INITIATION
somommmo
norw~r~a~
son HYnn.wry
R.E. Kouri,
C.J. Henry,
, .,
>+--BIOCB-IEMICAL PROMOTION--
A-%
CELLULAR
PROMOTION
FACTaRS N
TllMOii GF'iOVVrH
.aaaE staos
pens4a Ym...CaWlancw
inLe.wpp..won
~ FACTOM N
CELL
PROI.RRA170N
E~ooaer.ous
ew
W.moo
newwoa p`9
LxOCfnOUS
M41M
fAsmL W

HT®0120022
\
\
Figure 2. SEM II animal containment system. One side of the
unit is shown, with ~he capacity for exposing 240
mice per side (480 mice total) Rubber stoppers
are used in the exposure holes when less than the
full capacity of mice are to be exposed.
~a .*aadaww~C~ ~

(
.(
Figuse 2.
H TQ01 20023
~

4
Figure 3a,b. Animal restraint system, showing "stock-like H"T®0120024
r holder.

Figure 3a.
° ~~aausrmetirsLoar
Fi;ure 3b.

HT®0120026
Figure 4. The SEM II with front and side panels open to show
electronic componets. Cigarettes (C) are loaded from
a hopper (EO) into a rotating drum holder (DH). The
lighter (L) automatically ignites the cigarette and
puff air is forced through each cigarette in turn.
Flow is caused by a constantly held differential
pressure in the dome (DO) between the ignited end and
the btitt end of the cigarettes. Dilution air (DA) is
introduced at the butt end of the cigarettes. Side
stream smoke is removed through the vent (V). Ciga-
ettes are removed by the automatic ejector (E) and
discarded in the butt chute (S).

(
Fig. 5(a) Wsiton Hoeisontal Smoideg %IaehEae. Mice ue shoaa
teeQaiaed in the cyiindttcai eube&
~

t
Fig. 5(b) Waltaa expoetue eh-uaber. One sde plate haa been
temo.ed to show the inside bt espwuse chamber tCH) with the
canft¢Uyhaped exposuse holes (Zi) visible. Dunag an eaposute the
dgaeette- dome (p) moves foraraed and eutomaticallq igmtes the
dgetens IC). and 35 ml of puff air in fereed through the ciguette
into the- chamber. A contiouous+Iq rotating [an (F) is t*qnired to
enmssea rapid and unifotse mixiug of the smoke. At thb end of an
eslosuae iatetval, smoke is vented through the eshamt port (E).
H 11 I ...'r11 r ~U~~r L.9

e
n.
Ftcjure 6
Aw4ao1 CoMalnnrang end Smolso Flow Syatern
ClGAqETTES ~ T1 ~
AtR
aurometk i~f(Jon, jnm~P
pull ojoctlWe
d ~rqnt
=1t® OPTICAI.
QISTRIBUTiON SENSOG
VAI-VE
r
.r--,
Soct~ ol Pd~eplw~w~o Mwlulo
CGUes
STOCK TYPE
IIEAp IIESTRAINT
ANIMAL CONTAIPjb1ENT
1Ploee up Viaw ot Anbnal 1lsecralna /n /iolalion lo PdYaal+onslo MmW1o
IIEAD RESTRAINT
NOSE SEAL

\
Figure 7.
COMPREHENSIVE LA8ORATOttY ANIM1#L DIAGNOST,IC
AA1D MANAGEMENT SERVICE
IyDIVIDUAL ANIMAL DIAGNOSTIC REPORT
Client: Date Received:
Species/Strain: Date Necropsied
Group Designation: Date Completed:
Accession No.: Histology No.:
CLINICAL E:{AMINATION
PARASITOLOGY
External Parasites
Fecal Flotation
Direct (Cecal Contents)
Intestinal Wet Mount
Trichosomoides
BACTERIOLOGY
Oropharyngeal Culture
Feca]. Culture
Liver Culture
Other
VIRAL AND MYCOPLASMA SEROLOGY
M. pulmonis '(ELISA) LCM
ECTROMELIA PVK
KRV Reo3
MVM SENDAI
MHV (ELISA) K Virus
POLY PCV (ELISA)
GD-VII H-1
ADENO SVS
G'stOSS NECROPSY FINDINGS
H 100120031
X6.0iiai~ba01f~3c81 As61cocia!
.-W"Mft

HT10120032
Figure 7.
COMPREHENSIVE LABORATORY ANIMAL DIAGNOSTIC
AND MANAGEMENT SERVICE
MICROSCOPIC DIAGNOSES
OTHER
COMMENT
William C. Hall, V.M.D., Ph.D.
Veterinary Pathologist

Figure 7.
HT®0120033
\
COMPREHENSIVE LABORATORY ANIMAL DIAGNOSTIC
AND MANAGEMENT SERVICE
INDIVIDUAL ANIMAL DIAGNOSTIC REPORT
Client:
Species/Strain:
Group Designation:
Accession No.:
CLINICAL EXAMINATION Date Received:
Date Necropsied
Date Completed:
Histology No.:
PARASITOLOGY
l External Parasites
Fecal Flotation
Direct (Cecal Contents)
Intestinal Wet Mount
Trichosomoides
BACPE?ZIOLOGY
Oropharyngeal Culture
Fecal Culture
Liver Culture
other
VIRAL AND MYCOPI,ASMA SEROLOGY
M. pulmonis (ELISA) LCM
ECTI:ONELIe1 PVNi
KRV Reo3
MVM SENDAI
MSV (ELISA) K Virus
POLY PCV ( E:.ISA )
Gh-VII s-1
ADENO SV 5
GROSS NECROPSY FINDINGS
m ~'~'CIoh10k0cal AwK3a1
~ ~ ~

---
